Gokhan Garip, Ekrem Kaya, Department of Surgery, Uludag University School of Medicine, 16059 Gorukle-Bursa, Turkey.
World J Gastroenterol. 2013 Nov 28;19(44):8065-70. doi: 10.3748/wjg.v19.i44.8065.
To evaluate the effects of disease severity and necrosis on organ dysfunctions in acute pancreatitis (AP).
One hundred and nine patients treated as AP between March 2003 and September 2007 with at least 6 mo follow-up were included. Patients were classified according to severity of the disease, necrosis ratio and localization. Subjective clinical evaluation and fecal pancreatic elastase-I (FPE-I) were used for exocrine dysfunction evaluation, and oral glucose tolerance test was completed for endocrine dysfunction. The correlation of disease severity, necrosis ratio and localization with exocrine and endocrine dysfunction were investigated.
There were 58 male and 51 female patients, and mean age was 56.5 ± 15.7. Of the patients, 35.8% had severe AP (SAP) and 27.5% had pancreatic necrosis. Exocrine dysfunction was identified in 13.7% of the patients [17.9% were in SAP, 11.4% were in mild AP (MAP)] and 34.7% of all of the patients had endocrine dysfunction (56.4% in SAP and 23.2% in MAP). In patients with SAP and necrotizing AP (NAP), FPE-Ilevels were lower than the others (P < 0.05 and 0.001 respectively) and in patients having pancreatic head necrosis or near total necrosis, FPE-1 levels were lower than 200 μg/g stool. Forty percent of the patients who had undergone necrosectomy developed exocrine dysfunction. Endocrine dysfunction was more significant in patients with SAP and NAP (P < 0.001). All of the patients in the necrosectomy group had endocrine dysfunction.
Patients with SAP, NAP, pancreatic head necrosis and necrosectomy should be followed for pancreatic functions.
评估疾病严重程度和坏死对急性胰腺炎(AP)器官功能障碍的影响。
纳入 2003 年 3 月至 2007 年 9 月期间至少随访 6 个月的 109 例 AP 患者。根据疾病严重程度、坏死率和定位对患者进行分类。采用主观临床评估和粪便胰腺弹性蛋白酶-1(FPE-1)评估外分泌功能障碍,口服葡萄糖耐量试验评估内分泌功能障碍。研究了疾病严重程度、坏死率和定位与外分泌和内分泌功能障碍的相关性。
患者中男性 58 例,女性 51 例,平均年龄 56.5±15.7 岁。35.8%为重症急性胰腺炎(SAP),27.5%有胰腺坏死。13.7%的患者存在外分泌功能障碍[17.9%为 SAP,11.4%为轻症急性胰腺炎(MAP)],34.7%的患者存在内分泌功能障碍(SAP 为 56.4%,MAP 为 23.2%)。SAP 和坏死性急性胰腺炎(NAP)患者的 FPE-I 水平较低(分别为 P<0.05 和 P<0.001),胰头坏死或近乎全部坏死患者的 FPE-1 水平低于 200μg/g 粪便。40%接受坏死清除术的患者发生外分泌功能障碍。SAP 和 NAP 患者的内分泌功能障碍更显著(P<0.001)。所有接受坏死清除术的患者均存在内分泌功能障碍。
SAP、NAP、胰头坏死和坏死清除术的患者应随访胰腺功能。